Pharma’s Programmatic Problem: Precision Without Proof

By Kamya Elawadhi - When did "we believe we reached physicians" become an acceptable standard for a billion-dollar industry? Somewhere along the way, pharma marketing made peace with probabilistic targeting, inferred identities, and impression counts that looked impressive but proved little.